A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Xp13512/Gsk1838262 in the Treatment of Patients With Primary Restless Legs Syndrome-Reference-Cited by-同舟云学术

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Xp13512/Gsk1838262 in the Treatment of Patients With Primary Restless Legs Syndrome

Published:2009-02-01 Issue:2 Volume:32 Page:159-168
ISSN:0161-8105
Container-title:Sleep
language:en
Short-container-title:

Author:

Kushida Clete A.¹,Walters Arthur S.²,Becker Philip³,Thein Stephen G.⁴,Perkins A. Thomas⁵,Roth Thomas⁶,Canafax Daniel⁷,Barrett Ronald W.⁸,

Affiliation:

1. Stanford University Center of Excellence for Sleep Disorders, Stanford, CA

2. New Jersey Neuroscience Institute at JFK Medical Center, Seton Hall University School of Graduate Medical Education, Edison, NJ

3. Sleep Medicine Associates of Texas, Dallas, TX

4. Pacific Research Network, San Diego, CA

5. Sleep Medicine Program at Raleigh Neurology Associates, Raleigh, NC

6. Henry Ford Hospital, Detroit, MI

7. ARYx Therapeutics, Freemont, CA

8. XenoPort, Inc., Santa Clara, CA

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Clinical Neurology

Link

http://academic.oup.com/sleep/article-pdf/32/2/159/13664463/sleep-32-2-159.pdf

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological responsiveness of periodic limb movements in patients with restless legs syndrome: a systematic review and meta-analysis;Journal of Clinical Sleep Medicine;2023-04

2. Transporter-Mediated Drug Delivery;Molecules;2023-01-24

3. Why It Is Important to Consider the Effects of Analgesics on Sleep: A Critical Review;Comprehensive Physiology;2021-09-23

4. Noninvasive neuromodulation reduces symptoms of restless legs syndrome;Journal of Clinical Sleep Medicine;2021-08

5. Sleep Disturbance, Sleep Disorders and Co-Morbidities in the Care of the Older Person;Medical Sciences;2021-05-21